Post‐surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID‐19.
There are increasing reports of autoimmune and dermatologic sequelae of COVID‐19. We describe an otherwise healthy patient with recent history of serious COVID‐19 infection who developed post‐surgical pyoderma gangrenosum following bilateral reduction mammoplasty and was successfully treated with in...
| Publicado en: | Breast Journal Vol. 27; no. 8; pp. 671 - 675 |
|---|---|
| Autores principales: | , , |
| Formato: | case study pictorial tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Aug2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151852714&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 151852714 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1075122X ET6 jtl: Breast Journal issn: 1075122X maglogo: Y pubinfo: dt: Aug2021 vid: 27 iid: 8 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 151852714 150450293 151852714 151852714 10.1111/tbj.14242 151852714 ppf: 671 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: C – @attributes: type: P tig: atl: Post‐surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID‐19. aug: au: Rich, Matthew D. Sorenson, Thomas J. Schubert, Warren affil: Division of Plastic Surgery, Department of Surgery, University of Minnesota, Minneapolis MN,, USA sug: subj: COVID-19 Breast Reconstruction Postoperative Complications Pyoderma Gangrenosum Female Adult Autoimmune Diseases Risk Factors Infliximab Therapeutic Use Mycophenolic Acid Therapeutic Use Adrenal Cortex Hormones Therapeutic Use Adult: 19-44 years Female ab: There are increasing reports of autoimmune and dermatologic sequelae of COVID‐19. We describe an otherwise healthy patient with recent history of serious COVID‐19 infection who developed post‐surgical pyoderma gangrenosum following bilateral reduction mammoplasty and was successfully treated with infliximab, mycophenolic acid, and corticosteroids. We present this case to highlight the lingering systemic proinflammatory effects of COVID‐19 infection that may increase the risk of rare autoimmune complications of surgery. As a complete understanding of the long‐term effects of COVID‐19 is poorly understood, patients with a history of COVID‐19 infection should be appropriately counseled to these possible risks when discussing surgery. pubtype: Academic Journal doctype: case study pictorial tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|